Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Genotyping Market, by Product
1.4.2 Europe Genotyping Market, by Application
1.4.3 Europe Genotyping Market, by End Use
1.4.4 Europe Genotyping Market, by Technology
1.4.5 Europe Genotyping Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Strategies deployed in Genotyping Market
Chapter 4. Europe Genotyping Market by Product
4.1 Europe Reagents & Kits Market by Country
4.2 Europe Instruments Market by Country
4.3 Europe Software & Services Market by Country
Chapter 5. Europe Genotyping Market by Application
5.1 Europe Diagnostics & Personalized Medicine Market by Country
5.2 Europe Agricultural Biotechnology Market by Country
5.3 Europe Pharmacogenomics Market by Country
5.4 Europe Animal Genetics Market by Country
5.5 Europe Others Market by Country
Chapter 6. Europe Genotyping Market by End Use
6.1 Europe Diagnostics & Research Laboratories Market by Country
6.2 Europe Pharmaceutical & Biopharmaceutical Companies Market by Country
6.3 Europe Academic Institutes Market by Country
6.4 Europe Others Market by Country
Chapter 7. Europe Genotyping Market by Technology
7.1 Europe PCR Market by Country
7.2 Europe Sequencing Market by Country
7.3 Europe Capillary Electrophoresis Market by Country
7.4 Europe Microarray Market by Country
7.5 Europe Mass Spectrometry Market by Country
7.6 Europe Others Market by Country
Chapter 8. Europe Genotyping Market by Country
8.1 Germany Genotyping Market
8.1.1 Germany Genotyping Market by Product
8.1.2 Germany Genotyping Market by Application
8.1.3 Germany Genotyping Market by End Use
8.1.4 Germany Genotyping Market by Technology
8.2 UK Genotyping Market
8.2.1 UK Genotyping Market by Product
8.2.2 UK Genotyping Market by Application
8.2.3 UK Genotyping Market by End Use
8.2.4 UK Genotyping Market by Technology
8.3 France Genotyping Market
8.3.1 France Genotyping Market by Product
8.3.2 France Genotyping Market by Application
8.3.3 France Genotyping Market by End Use
8.3.4 France Genotyping Market by Technology
8.4 Russia Genotyping Market
8.4.1 Russia Genotyping Market by Product
8.4.2 Russia Genotyping Market by Application
8.4.3 Russia Genotyping Market by End Use
8.4.4 Russia Genotyping Market by Technology
8.5 Spain Genotyping Market
8.5.1 Spain Genotyping Market by Product
8.5.2 Spain Genotyping Market by Application
8.5.3 Spain Genotyping Market by End Use
8.5.4 Spain Genotyping Market by Technology
8.6 Italy Genotyping Market
8.6.1 Italy Genotyping Market by Product
8.6.2 Italy Genotyping Market by Application
8.6.3 Italy Genotyping Market by End Use
8.6.4 Italy Genotyping Market by Technology
8.7 Rest of Europe Genotyping Market
8.7.1 Rest of Europe Genotyping Market by Product
8.7.2 Rest of Europe Genotyping Market by Application
8.7.3 Rest of Europe Genotyping Market by End Use
8.7.4 Rest of Europe Genotyping Market by Technology
Chapter 9. Company Profiles
9.1 F. Hoffmann-La Roche Ltd.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expense
9.1.1 Recent strategies and developments:
9.1.1.1 Partnerships, Collaborations, and Agreements:
9.2 Danaher Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 Recent strategies and developments:
9.2.5.1 Acquisition and Mergers:
9.3 Agilent Technologies, Inc.
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.4 Thermo Fisher Scientific, Inc.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expense
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.5 Qiagen N.V.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Partnerships, Collaborations, and Agreements:
9.6 Illumina, Inc.
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Partnerships, Collaborations, and Agreements:
9.6.5.2 Product Launches and Product Expansions:
9.7 Bio-Rad laboratories, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.8 Eurofins Scientific Group
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Regional Analysis
9.8.4 Recent strategies and developments:
9.8.4.1 Acquisition and Mergers:
9.9 Fluidigm Corporation
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Regional Analysis
9.9.4 Research & Development Expenses
Unique Offerings 